DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
183 hedge funds and large institutions have $1.61B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 55 increasing their positions, 67 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
18% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 67
38% less call options, than puts
Call options by funds: $5.27M | Put options by funds: $8.48M
Holders
183
Holding in Top 10
5
Calls
$5.27M
Puts
$8.48M
Top Buyers
| 1 | +$34.6M | |
| 2 | +$27.7M | |
| 3 | +$20.5M | |
| 4 |
AG
Artal Group
Luxembourg
|
+$20.5M |
| 5 |
BM
Bridger Management
New York
|
+$15.1M |
Top Sellers
| 1 | -$45M | |
| 2 | -$36.2M | |
| 3 | -$21M | |
| 4 |
Renaissance Technologies
New York
|
-$13.8M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$11.6M |